Headquartered in Rockville, MD, Supernus Pharmaceuticals is a specialty pharmaceutical company dedicated to improving the lives of people suffering from diseases of the central nervous system (CNS).

Supernus is developing medicines that improve patient compliance, decrease the occurrence of side effects, and address unmet medical needs.

Our heritage of more than 20 years of successfully developing products that use our innovative technologies has yielded a robust pipeline of differentiated CNS products. These products have a lower risk profile, large market potential, shorter timelines to market, and newly created intellectual property.

Our vision is to be a leading neuroscience specialty pharmaceutical company developing and marketing proprietary products. We plan on building our commercial organization with dedicated sales force for the neurology and psychiatry specialty areas. We will seek partners for primary care and ex-US markets.